(Q63812897)

English

Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD)

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD); Prospective, Double Blind, Randomized Placebo-control, Multi-center Study (English)

0 references

medical condition

hyperplasia

0 references

bronchopulmonary dysplasia

0 references

country

Israel

0 references

start time

June 2011

0 references

end time

June 2016

0 references

number of participants

60

0 references

clinical trial phase

phase II clinical trial

0 references

research site

Bnai Zion Medical Center

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT01373008

0 references

(Q63812897)

Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)